Capital Asset Advisory Services LLC Morpho Sys Ag Transaction History

Capital Asset Advisory Services LLC

  • $1.82 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 06, 2021
SELL
$18.95 - $23.95 $225,846 - $285,436
-11,918 Closed
0 $0
Q1 2021

May 13, 2021
BUY
$21.56 - $30.66 $79,966 - $113,717
3,709 Added 45.18%
11,918 $260,000
Q4 2020

Mar 02, 2021
BUY
$24.81 - $30.33 $203,665 - $248,978
8,209 New
8,209 $233,000

Others Institutions Holding MOR

# of Institutions
43
Shares Held
1.84M
Call Options Held
79.8K
Put Options Held
688K
View Full List

About MorphoSys AG

MOR Quotes by TradingView
  • Ticker MOR
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 136,614,000
  • Description
  • MorphoSys AG, a commercial-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutic antibodies for patients suffering from cancer and autoimmune diseases in the United States. It offers Tafasitamab, an antibody for the treatment of B cell malignancies, including diffuse large B-cell lymphoma, f...
More about MOR
Track This Portfolio

Track Capital Asset Advisory Services LLC Portfolio

Follow Capital Asset Advisory Services LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Asset Advisory Services LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capital Asset Advisory Services LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email